Abstract
Insulin resistance is getting important in the course of type 1 diabetes mellitus. Visceral fat depot is associated with insulin resistance and assessment of epicardial fat thickness is a way of measuring visceral fat. The aim of the study was to measure epicardial adipose tissue (EAT) thickness and to determine its relationship with waist-hip-ratio (WHR) and estimated glucose disposal rate (eGDR) in adult type 1 diabetic patients. Thirty-six type 1 diabetic patients (aged 31 ± 8 years; Female/Male: 22/14) and 43 age, gender and BMI matched healthy controls were included. Fasting blood glucose (FBG), hemoglobin A1c, and lipid profiles were measured. Waist-hip-ratio (WHR) was calculated. Daily insulin dose/kg of patients were recorded and eGDR of all subjects was calculated. Epicardial adipose tissue (EAT) thickness was evaluated by echocardiography. EAT thickness of the type 1 diabetic patients was significantly higher than controls (3.30 ± 1.06 vs. 2.30 ± 0.34 mm, P < 0.0001). EAT thickness was correlated with age (P = 0.05; r = 0.35), WHR (P = 0.003; r = 0.67), daily insulin dose/kg (r = 0.45, P = 0.005), and eGDR (r = −0.55, P = 0.0004). Multivariate analysis revealed WHR and eGDR to be related to EAT among age, WHR, daily insulin dose/kg, eGDR, FBG, and hemoglobin A1c (r2 of the model = 0.64). Epicardial adipose tissue thickness is increased in type 1 diabetic patients compared to controls and is related to WHR and eGDR in this group of patients. This measurement may point to the presence of insulin resistance in type 1 diabetic patients.
Similar content being viewed by others
References
S.S. Soedamah-Muthu, J.H. Fuller, H.E. Mulnier, V.S. Raleigh, R.A. Lawrenson, H.M. Colhoun, All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia 49, 660–666 (2006)
G. Pambianco, T. Costacou, D. Ellis, D.J. Becker, R. Klein, T.J. Orchard, The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 55, 1463–1469 (2006)
E. Bonora, G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, L. Zenari, F. Saggiani, M. Poli, S. Perbellini, A. Raffaelli, V. Cacciatori, L. Santi, G. Targher, R. Bonadonna, M. Muggeo, HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 25, 1135–1141 (2002)
A.J. Hanley, K. Williams, M.P. Stern, S.M. Haffner, Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25, 1177–1184 (2002)
E.S. Kilpatrick, A.S. Rigby, S.L. Atkin, Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the DiabetesControl and Complications Trial. Diabetes Care 30, 707–712 (2007)
T.J. Orchard, J.C. Olson, J.R. Erbey, K. Williams, K.Y. Forrest, L. Smithline Kinder, D. Ellis, D.J. Becker, Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 26, 1374–1379 (2003)
S.S. Soedamah-Muthu, N. Chaturvedi, M. Toeller, B. Ferriss, P. Reboldi, G. Michel, C. Manes, J.H. Fuller, EURODIAB Prospective Complications Study Group: risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 27, 530–537 (2004)
M. McGill, L. Molyneaux, S.M. Twigg, D.K. Yue, The metabolic syndrome in type 1 diabetes: does it exist and does it matter? J. Diabetes Complicat. 22, 18–23 (2008)
K.M. Rexrode, J.E. Buring, J.E. Manson, Abdominal and total adiposity and risk of coronary heart disease in men. Int. J. Obes. Relat. Metab. Disord. 25, 1047–1056 (2001)
K.M. Rexrode, V.J. Carey, C.H. Hennekens, E.E. Walters, G.A. Colditz, M.J. Stampfer, W.C. Willett, J.E. Manson, Abdominal adiposity and coronary heart disease in women. JAMA 280, 1843–1848 (1998)
A.N. Peiris, M.S. Sothmann, R.G. Hoffmann, M.I. Hennes, C.R. Wilson, A.B. Gustafson, A.H. Kissebah, Adiposity, fat distribution, and cardiovascular risk. Ann. Intern. Med. 110, 867–872 (1989)
G. Iacobellis, F. Assael, M.C. Ribaudo, A. Zappaterreno, G. Alessi, U. Di Mario, F. Leonetti, Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes. Res. 11, 304–310 (2003)
J. Shirani, K. Berezowski, W.C. Roberts, Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. Am. J. Cardiol. 76, 414–418 (1995)
G. Iacobellis, M.C. Ribaudo, F. Assael, E. Vecci, C. Tiberti, A. Zappaterreno, U. Di Mario, F. Leonetti, Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J. Clin. Endocrinol. Metab. 88, 5163–5168 (2003)
A.E. Malavazos, F. Ermetici, C. Coman, M.M. Corsi, L. Morricone, B. Ambrosi, Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity. Int. J. Cardiol. 121, 132–134 (2007)
G. Iacobellis, F. Leonetti, N. Singh, A.M. Sharma, Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. Int. J. Cardiol. 115, 272–273 (2007)
H. Aydin, A. Toprak, O. Deyneli, D. Yazici, O. Tarçin, S. Sancak, D. Yavuz, S. Akalin, Epicardial fat tissue thickness correlates with endothelial dysfunction and other cardiovascular risk factors in patients with metabolic syndrome. Metab. Syndr. Relat. Disord. 8, 229–234 (2010)
R. Taguchi, J. Takasu, Y. Itani, R. Yamamoto, K. Yokoyama, S. Watanabe, Y. Masuda, Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis 157, 203–209 (2001)
G. Iacobellis, A.M. Sharma, Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome. Curr. Pharm. Des. 13, 2180–2184 (2007)
A.M. de Vos, M. Prokop, C.J. Roos, M.F. Meijs, Y.T. van der Schouw, A. Rutten, P.M. Gorter, M.J. Cramer, P.A. Doevendans, B.J. Rensing, M.L. Bartelink, B.K. Velthuis, A. Mosterd, M.L. Bots, Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur. Heart J. 29, 777–783 (2008)
L.M. Thorn, C. Forsblom, J. Fagerudd, M.C. Thomas, K. Pettersson-Fernholm, M. Saraheimo, J. Wadén, M. Rönnback, M. Rosengård-Bärlund, C.G. Björkesten, M.R. Taskinen, P.H. Groop, FinnDiane Study Group: metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28, 2019–2024 (2005)
G. Pambianco, T. Costacou, T.J. Orchard, The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes Care 30, 1248–1254 (2007)
K.V. Williams, J.R. Erbey, D. Becker, S. Arslanian, T.J. Orchard, Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 49, 626–632 (2000)
E. Ho, Y. Shimada, Formation of the epicardium studied with the scanning electron microscope. Dev. Biol. 66, 579–585 (1978)
J.M. Marchington, C.A. Mattacks, C.M. Pond, Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Biochem. Physiol. B. 94, 225–232 (1989)
G. Iacobellis, G. Barbaro, The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm. Metab. Res. 40, 442–445 (2008)
N. Chaowalit, V.K. Somers, P.A. Pellikka, C.S. Rihal, F. Lopez-Jimenez, Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis 186, 354–359 (2006)
R. Djaberi, J.D. Schuijf, J.M. Van Werkhoven, G. Nucifora, J.W. Jukema, J.J. Bax, Relation of epicardial adipose tissue to coronary atherosclerosis. Am. J. Cardiol. 102, 1602–1607 (2008)
S. Eroglu, L.E. Sade, A. Yildirir, U. Bal, S. Ozbicer, A.S. Ozgul, H. Bozbas, A. Aydinalp, H. Muderrisoglu, Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr. Metab. Cardiovasc. Dis. 19, 211–217 (2009)
C.P. Wang, H.L. Hsu, W.C. Hung, T.H. Yu, Y.H. Chen, C.A. Chiu, L.F. Lu, F.M. Chung, S.J. Shin, Y.J. Lee, Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin. Endocrinol. (Oxf.) 70, 876–882 (2009)
G. Iacobellis, F. Leonetti, Epicardial adipose tissue and insulin resistance in obese subjects. J. Clin. Endocrinol. Metab. 90, 6300–6302 (2005)
G. Iacobellis, G. Barbaro, H.C. Gerstein, Relationship of epicardial fat thickness and fasting glucose. Int. J. Cardiol. 128, 424–426 (2008)
N. Mattsson, T. Rönnemaa, M. Juonala, J.S. Viikari, O.T. Raitakari, The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. J. Intern. Med. 261, 159–169 (2007)
J. Nádas, Z. Putz, J. Fövényi, Z. Gaál, A. Gyimesi, T. Hídvégi, N. Hosszúfalusi, G. Neuwirth, T. Oroszlán, P. Pánczél, G. Széles, G. Vándorfi, G. Winkler, I. Wittmann, G. Jermendy, Cardiovascular risk factors characteristic for the metabolic syndrome in adult patients with type 1 diabetes. Exp. Clin. Endocrinol. Diabetes 117, 107–112 (2009)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yazıcı, D., Özben, B., Yavuz, D. et al. Epicardial adipose tissue thickness in type 1 diabetic patients. Endocrine 40, 250–255 (2011). https://doi.org/10.1007/s12020-011-9478-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-011-9478-x